BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 17215092)

  • 1. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
    Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
    Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice.
    Wang X; Jiang W; Jiang P; Li Y; Feng Z; Xu J
    Vaccine; 2006 Apr; 24(16):3374-80. PubMed ID: 16524646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.
    Ostanello F; Caprioli A; Di Francesco A; Battilani M; Sala G; Sarli G; Mandrioli L; McNeilly F; Allan GM; Prosperi S
    Vet Microbiol; 2005 Jul; 108(3-4):179-86. PubMed ID: 15916871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
    Kixmöller M; Ritzmann M; Eddicks M; Saalmüller A; Elbers K; Fachinger V
    Vaccine; 2008 Jun; 26(27-28):3443-51. PubMed ID: 18513842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
    Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
    Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms.
    Segalés J; Urniza A; Alegre A; Bru T; Crisci E; Nofrarías M; López-Soria S; Balasch M; Sibila M; Xu Z; Chu HJ; Fraile L; Plana-Duran J
    Vaccine; 2009 Dec; 27(52):7313-21. PubMed ID: 19800439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.
    Fort M; Olvera A; Sibila M; Segalés J; Mateu E
    Vet Microbiol; 2007 Dec; 125(3-4):244-55. PubMed ID: 17611048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
    Seo HW; Han K; Park C; Chae C
    Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
    Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
    Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of an effect of a commercial vaccine adjuvant on the development of postweaning multisystemic wasting syndrome (PMWS) in porcine circovirus type 2 (PCV2) experimentally infected conventional pigs.
    Resendes A; Segalés J; Balasch M; Calsamiglia M; Sibila M; Ellerbrok H; Mateu E; Plana-Durán J; Mankertz A; Domingo M
    Vet Res; 2004; 35(1):83-90. PubMed ID: 15099505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions.
    Seo HW; Han K; Oh Y; Park C; Chae C
    Vaccine; 2012 Oct; 30(47):6671-7. PubMed ID: 22963801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice.
    Fan H; Pan Y; Fang L; Wang D; Wang S; Jiang Y; Chen H; Xiao S
    J Virol Methods; 2008 Jun; 150(1-2):21-6. PubMed ID: 18394722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome.
    Larochelle R; Magar R; D'Allaire S
    Can J Vet Res; 2003 May; 67(2):114-20. PubMed ID: 12760476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2.
    Horlen KP; Dritz SS; Nietfeld JC; Henry SC; Hesse RA; Oberst R; Hays M; Anderson J; Rowland RR
    J Am Vet Med Assoc; 2008 Mar; 232(6):906-12. PubMed ID: 18341450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
    Alberti KA; Estienne MJ; Meng XJ
    J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.